This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology, Other  • Alert me on articles by topic

Arch Dermatol. 2000;136:71-73.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The challenges facing dermatologists in the third millennium are many. Some of them are difficult to predict at the present time. For at least the first decade of the third millennium, however, it is reasonable to predict that the incidence of melanoma will continue to rise. Although public health exercises aimed at prevention have now been in place for over 15 years, there are very few data to suggest that the incidence of melanoma is leveling off. Thus, dermatologists should be prepared to see more cases of melanoma, and most likely at an earlier stage of disease. This, in turn, means that the relative proportion of melanoma-related clinical work will fall more heavily on the dermatologist than was previously the case, because it is unlikely that extensive surgery will be needed in most instances.

EPIDEMIOLOGY

A recent publication in the ARCHIVES from the Surveillance, Epidemiology, and End Results Program Registry¹ suggested . . . [Full Text of this Article]

EARLY DIAGNOSIS

SURGERY

PATHOLOGICAL EVALUATION

ADDITIONAL SURGICAL PROCEDURES

ADJUVANT THERAPY

PREVENTION OF MELANOMA

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cytotoxicity, DNA Damage, and Apoptosis Induced by New Fotemustine Analogs on Human Melanoma Cells in Relation to O6-Methylguanine DNA-Methyltransferase Expression
Passagne et al.
J. Pharmacol. Exp. Ther. 2003;307:816-823.
ABSTRACT | FULL TEXT